Trial intelligence / Profile preview

Propranolol after CO2-induced fear memory reactivation in panic disorder

2015-005338-23Phase 2Active

Sponsor
University of Amsterdam
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of propranolol in panic disorder, sponsored by University of Amsterdam. Primary endpoint: Absence of panic disorder diagnosis and symptom reduction. Started Jul 2016; status: active.

02

Drugs

propranolol
03

Conditions

panic disorder

Beyond the preview

Go deeper on 2015-005338-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-005338-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call